MAPT and Alzheimer disease: As expected, reduction of tau protein from both SARK and HMW samples (Supplementary Fig. 4a) almost completely abolishes in vitro seeding activity, lowering it to the same level as SARK and HMW tau samples from a non-AD control case (Supplementary Fig. 4b-c).